Navigation Links
ACORN Contract Research Organization Appoints Tara Webb as Senior Director of CRO Business Development

MEMPHIS, Tenn., Sept. 22 /PRNewswire/ -- Accelerated Community Oncology Research Network (ACORN) (TM), a national oncology-focused Contract Research Organization (CRO) and clinical trial network, announced today that it has named Tara Webb as Senior Director of Business Development. Webb brings a successful record of establishing and cultivating CRO relationships. "Tara Webb has an exceptional background of work in the CRO field and is widely respected for her industry knowledge, capabilities and integrity," remarked Edward J. Stepanski, PhD, Chief Operations Officer of ACORN. "Her responsibilities at ACORN CRO will include presenting ACORN's capabilities to pharmaceutical companies and emerging biotechs, forging alliances with key accounts and providing customer service oversight on behalf of clients." Most recently, Webb served as Senior Director, Business Development for i3 Statprobe, where she was responsible for developing new business opportunities and strengthening current client relationships both nationally and internationally.

(Logo: )

ACORN CRO will provide Webb with the platform to focus her energies exclusively in the field of oncology, thus enabling closer working relationships with a select group of sponsors. "Tara Webb is an excellent fit with our organization as she is known for her dedication and determination to consistently provide her clients and their projects with uncompromising standards of quality," stated Steve Coplon, ACORN CEO. "With a decade of research experience augmented by a strong, technological background, she will provide excellent representation of ACORN CRO's scientific strength, unprecedented community oncology relationships, and ACORN's proprietary technology, including Guardian EDC(TM)," added Coplon.

Webb holds a M.S. in Organizational Leadership & Administration and a B.S. in Health Administration (Accelerated Program) from Concordia College, Ann Arbor, Michigan.


ACORN CRO provides a full range of research services to sponsors, from clinical trial design to site selection to the results phase with bioanalysis and findings presentation. Exclusively focused on oncology, ACORN CRO is backed by scientists and medical professionals dedicated to advancing cancer care through research. An important added strength resides in ACORN's network of community oncology researchers, specifically selected for their commitment to oncology research and excellence in its execution. ACORN, Inc., a privately held company, significantly enhances the speed, accuracy, and productivity of conducting clinical research in the community oncology setting. Proactive project management with focused teams of clinical experts achieves these goals. Well-defined processes augmented by proprietary technology provide oversight and efficiencies on study functions for both pharma and participating sites.

Webb can be reached at or (901) 435-5570.

For additional information, contact Liz Conway, Director of Marketing and Corporate Services, 901-259-0878 or visit .

Accelerated Community Oncology Research Network, Inc. (TM) (ACORN) ACORN focuses on oncology exclusively. ACORN offers centralized clinical trial services, scientific analysis, and is a full-service Contract Research Organization (CRO), providing contract and budgeting services; fostering accrual of subjects at the site level; collecting data and monitoring its accuracy; and working seamlessly with both trial sponsors and participating practices.

Contact Information:

Liz Conway

(901) 435-5570

Deborah D. Coble


SOURCE Accelerated Community Oncology Research Network
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ACORN Expands Oncology Information Portfolio With Comprehensive Data Warehouse
2. Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx
3. Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
4. Microchip Biotechnologies, Inc. Awarded Contract Under US Army Commercialization Pilot Program
5. Environmental Tectonics Corporations Sterilization Systems Group Announces New Contracts
6. Valley Baptist Health System Selects Concuitys ClearContracts to More Accurately Calculate Payments from Managed Care and Government Payers
7. Therapure Biopharma Inc. opens for business with first client contracts
8. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
9. Advanced Life Sciences Awarded U.S. Department of Defense Biodefense Contract Valued at up to $3.8 Million
10. Sales Contracts Worth $2.3 Million Signed Since 1 July 2008
11. [video] Edward Spink, CEO of TurboSonic Technologies, Inc. Discusses Contract With Biofuel Producer in Exclusive Interview on WallSt.nets 3-Minute Press Show
Post Your Comments:
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Ky. , June 23, 2016 ... two Phase 1 clinical trials of its complement ... placebo-controlled, single and multiple ascending dose studies designed ... pharmacodynamics (PD) of subcutaneous injection in healthy adult ... subcutaneously (SC) either as a single dose (ranging ...
(Date:6/23/2016)... ... June 23, 2016 , ... Regulatory Compliance Associates® Inc. (RCA), ... free webinar on Performing Quality Investigations: Getting to Root Cause. ... no charge. , Incomplete investigations are still a major concern to the Regulatory ...
Breaking Biology Technology:
(Date:6/22/2016)... , June 22, 2016 On Monday, the ... to industry to share solutions for the Biometric Exit ... Customs and Border Protection (CBP), explains that CBP intends ... departing the United States , in ... to defeat imposters. Logo - ...
(Date:6/20/2016)... 20, 2016 Securus Technologies, a leading ... for public safety, investigation, corrections and monitoring announced ... it has secured the final acceptance by all ... Managed Access Systems (MAS) installed. Furthermore, Securus will ... be installed by October, 2016. MAS distinguishes between ...
(Date:6/15/2016)... ALBANY, New York , June 15, 2016 ... published a new market report titled "Gesture Recognition Market ... Trends and Forecast, 2016 - 2024". According to the ... at USD 11.60 billion in 2015 and is ... and reach USD 48.56 billion by 2024.  ...
Breaking Biology News(10 mins):